Portuguese validation of the Cambridge pulmonary hypertension outcome review (CAMPHOR) questionnaire

A. Reis, J. Twiss, M. Vicente, F. Gongalves, L. Carvalho, A. Melo, S. P. McKena, L. Almeida (Porto, Aviero, Portugal; Manchester, United Kingdom)

Source: International Congress 2014 – Pulmonary hypertension: clinical management
Session: Pulmonary hypertension: clinical management
Session type: Thematic Poster Session
Number: 2380
Disease area: Pulmonary vascular diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Reis, J. Twiss, M. Vicente, F. Gongalves, L. Carvalho, A. Melo, S. P. McKena, L. Almeida (Porto, Aviero, Portugal; Manchester, United Kingdom). Portuguese validation of the Cambridge pulmonary hypertension outcome review (CAMPHOR) questionnaire. Eur Respir J 2014; 44: Suppl. 58, 2380

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Correlations between clinical variables and quality of life in pulmonary arterial hypertension
Source: International Congress 2014 – Pulmonary hypertension: clinical management
Year: 2014


Examination about what determine quality of life (QOL) and the association between QOL and therapeutic intervention for patients with chronic thromboembolitic pulmonary hypertension (CTEPH)
Source: International Congress 2014 – Pulmonary hypertension: clinical management
Year: 2014

A retrospective study of depressive illness in patients with pulmonary hypertension (PH) at a specialist centre
Source: International Congress 2014 – Pulmonary hypertension: clinical management
Year: 2014


Long-term data from the Swiss pulmonary hypertension registry
Source: International Congress 2014 – Pulmonary hypertension: clinical management
Year: 2014

Prognostic value of outcome variables at follow-up in patients with PAH
Source: International Congress 2014 – Chronic thromboembolic pulmonary hypertension
Year: 2014

Studying quality of life in PAH: Patient-reported outcome assessment and psychosocial evaluation in a 6 months follow-up
Source: International Congress 2014 – Pulmonary hypertension: clinical management
Year: 2014

Portopulmonary hypertension in United Kingdom: A contemporary, national, observational study
Source: International Congress 2014 – Pulmonary hypertension in lung disease
Year: 2014

Global burden of chronic thromboembolic pulmonary hypertension (CTEPH): An epidemiological analysis
Source: International Congress 2014 – Chronic thromboembolic pulmonary hypertension
Year: 2014


Quality of life of patients with pulmonary arterial hypertension associated with congenital heart disease: The multicenter cross-sectional ACHILLE study
Source: International Congress 2014 – Pulmonary hypertension: clinical management
Year: 2014


Impact of pulmonary endarterectomy (PEA) on quality of life as assessed by CAMbridge Pulmonary Hypertension Outcome Review (CAMPHOR)
Source: Eur Respir J 2006; 28: Suppl. 50, 403s
Year: 2006

The responsiveness and validity of the CAMPHOR Utility Index
Source: Eur Respir J 2008; 32: 1513-1519
Year: 2008



Single center experience with systematic diagnostic and predictive genetic screening for pulmonary arterial hypertension
Source: International Congress 2014 – Pulmonary hypertension: clinical management
Year: 2014

Does Wells score documentation really prevent excessive CTPA requests in a teaching hospital? A retrospective study in 800 patients
Source: International Congress 2014 – Acute pulmonary embolism
Year: 2014


Epoprostenol dosing by concomitant therapies in the PROSPECT registry
Source: International Congress 2014 – Pulmonary hypertension: clinical management
Year: 2014

Relevance of echocardiographic composite index to improve the detection of pulmonary hypertension
Source: International Congress 2014 – Pulmonary hypertension: clinical management
Year: 2014

Characteristics of patients with pulmonary hypertension in end stage renal disease
Source: International Congress 2014 – Pulmonary hypertension in lung disease
Year: 2014

Nebivolol and pulmonary hypertension
Source: International Congress 2014 – Pulmonary hypertension: pathobiology
Year: 2014

Non-invasive cardiac output assessment in pulmonary hypertension
Source: International Congress 2014 – Pulmonary hypertension: right ventricle and basic physiology
Year: 2014

Immune signatures in pulmonary arterial hypertension
Source: International Congress 2014 – Pulmonary hypertension: novel targets and drugs
Year: 2014

Pulmonary arterial hypertension – A single-centre experience
Source: International Congress 2014 – Pulmonary hypertension: clinical management
Year: 2014